Funded Tech Companies
Elucid
Wondering who provided funding to Elucid? IAG Capital Partners, Elevage Medical Technologies and private investors joined the equity holders in this healthcare IT company.
Company Overview
Company Name
Elucid
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2 Park Plaza
Boston, MA 02116
USA
Boston, MA 02116
USA
Phone
Website
Email Address
Company Background Information
Overview
Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid equips physicians with critical information designed to enable precision medicine. Elucid is the first FDA-Cleared and CE-marked non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/2/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Blake Richards
President
Andrew Buckler
Vice President
Nasibeh Vatankhah
VP - Bus. Development
Jason Bottiglieri
VP - Engineering
Murali Ayyapillai
Company Investors
- IAG Capital Partners
- Elevage Medical Technologies
- Biovision Ventures
- Bold Brain Ventures
- BlueStone Venture Partners
- MedTex Ventures
- Willamette Valley Capital
- Checkmate Capital
- Angel Physicians Fund
- Global Health Impact Fund
- Wolverine Venture Fund
Browse more funded tech companies:
Elucent Medical | Elucida Oncology
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs